Committee on Mutagenicity of Chemicals in Food, Customer Products and the Environment (COM) - Call for Evidence

Closed 14 Aug 2015

Opened 6 Jul 2015


The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and Arm’s Length Bodies.

The Department holds the key stewardship and assurance function in order to ensure that the new system and its numerous reformed bodies are performing appropriate functions to a high standard.

To perform this stewardship function the Department is undertaking Triennial Reviews of all of its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Public Bodies (ANDPBs), Executive Agencies and Special Health Authorities. The Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM) is an ANDPB and is subject to review in 2015-16.

The programme of reviews uses the approach developed by the Cabinet Office as part of their work on public bodies reform.

Responding to the Call for Evidence

In order to conduct the review in a transparent manner and ensure findings are rigorous and evidence-based, the review team is seeking the views of a wide range of stakeholders. We are interested in the views of individuals and organisations that engage with COM or have a wider interest in its operations.

The call for evidence is running from 6 July 2015 to 14 August 2015.

Responses can be provided by completing the online survey below:


Interested stakeholders are also invited to attend a workshop 14:00 – 16:00 on 5 August 2015 to share their views. This workshop will consider both COM and COT and will be run in cooperation with the FSA. The workshop will be held at Richmond House, London, SW1A 2NS. You can book a place (places are limited and allocated on a first-come first-served basis) through this link:

Why We Are Consulting

As noted above, this review is part of a wider programme that the Department of Health has developed as part of its stewardship and assurance function. The review will have two main stages:

  • The first is to provide a robust challenge of the continuing need for COM both in terms of the functions it performs, and the way in which these are delivered.
  • If it is agreed that COM should retain its current function and utilise the same delivery model, the second stage of the review will then consider its performance, capability and governance, as well as considering opportunities for efficiencies.

This call for evidence seeks views from respondents to assist its consideration of both of the above stages.


  • Directors of Public Health
  • Healthcare scientists
  • Members of the public
  • Suppliers
  • Public Health Organisations
  • Members of the Public


  • Environment
  • Public health
  • Health protection
  • Health Protection Agency
  • Regulation